*This is a contract position for Tuesday Saturday during regular working hours*
About the Role
DELFI Diagnostics is seeking an exceptional Material Handler II with BioTechnology experience to join our growing organization. The Material Handler II hours of operation will be from Tuesday through Saturday 8:00am4:30pm.
Reporting to the Director of Facilities we are seeking an experienced Material Handler II who has a wide range of experience to support the companys continued growth. The selected candidate will own daytoday inventory management including but not limited to: MRP (material requirement planning) purchase order receipts (patient samples reagents consumables furniture critical equipment etc.. inventory adjustments inventory lab fulfillment kanban fulfillment qualified materials movements cycle counts MSS (Material Specification Sheet) process patient sample receipts and resolving purchase order and invoice discrepancies. The Material Handler II will also work crossfunctionally with laboratory personnel to ensure all labs are fully operational and well supplied with materials to minimize disruptions and will frequently collaborate with Clinical R&D IT Legal Procurement and Accounting teams as well. This person will embody our values champion datadriven decision making and partner clearly and effectively across functions.
About Us
DELFI Diagnostics Inc. (DELFI Diagnostics) is developing nextgeneration bloodbased tests that are reliable accessible and deliver a new way to help detect cancer. Employing advanced machinelearning methods to wholegenome sequencing data the DELFI (DNA EvaLuation of Fragments for early Interception) platform is built to address the highestburden health challenges. DELFI Diagnostics prioritizes solutions that have the potential to save lives on a global scale including for historically underserved populations. DELFI Diagnostics platform relies on fragmentomics the discovery that cancer cells are more chaotic than normal cells and when they die leave behind telltale patterns and characteristics of cellfree DNA (cfDNA) fragments. FirstLook Lung for individuals eligible for lung cancer screening is DELFI Diagnostics first laboratorydeveloped screening test and can be part of routine blood work. FirstLook Lung uses millions of data points to reliably identify individuals who may have cancer detected through lowdose CT including early stage disease with a negative predictive value of 99.7 percent. This test has not yet been cleared or approved by the FDA.
In our passionate pursuit to radically improve health outcomes we serve humanity when we:
Lead with Science Anchor in Pragmatism: We pioneer lifechanging science by ensuring quality transparency and rigor at all times. We explore thoughtfully experiment smartly and deliver impact with conviction.
Build With & For All: We embrace diverse backgrounds to innovate and achieve together. We are not just building a product we aim to disrupt the path of cancer for all no matter geography or socioeconomic class
Put We over I: We are a home for highperforming people. Through teamwork we build collective intelligence. Each of us wins when those we serve and those who serve with uswin. We show up with empathy humility and integrity at every step of the journey.
DELFI isnotopen to submissions or partnerships with recruitment agencies or search firms.
An equal opportunity employer
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race religion color national origin gender sexual orientation age marital status veteran status or disability status.